Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Can ‘Long COVID’ shine light on Chronic Fatigue Syndrome?
Can ‘Long COVID’ shine light on Chronic Fatigue Syndrome?

Honorary professor of general practice Campbell Murdoch played a key role in the recognition of chronic fatigue syndrome, 30 years ago. He reflects on then and now as studies suggest “Long COVID” is associated with an increased number of people experiencing CFS
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1.Editorial, 7 October 2020. Long COVID: let patients help define long-lasting COVID symptoms. Nature 586,170
2.Poore M, Snow P and Paul C. An unexplained illness in West Otago. NZ Med J 1984:97;351-4.
3.Snow P. Reminiscences of the chronic fatigue syndrome. NZ Family Physician 2002:29;385-6.
4.Sandler CX and Lloyd AR Chronic fatigue syndrome: progress and possibilities. Med J Aust 2020 May;212(9):428-433.
5.Lombardi VC et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science. 2009 23 Oct;326(5952):585-9.
6.Murdoch JC. Cell-mediated immunity in patients with myalgic encephalomyelitis syndrome. NZ Med J 1988;101:511-2.
7.Oldstone MBA Viral alteration of cell function. Scientific American August 1989:34-40.
8.Mackay A. A neuro-inflammatory model can explain the onset, symptoms and flare-ups of myalgic encephalomyelitis/chronic fatigue syndrome. J Prim. Health Care 2019;11:300-307.